Meeder Asset Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Meeder Asset Management’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-443	Closed	-$61K	–	2495
2021 Q3	$61K	Buy	443 +200	+82%	+$39.6K	﹤0.01%	1043
2021 Q2	$67K	Buy	243 +113	+87%	+$28.5K	﹤0.01%	1030
2021 Q1	$28K	Buy	+130	New	+$35.9K	﹤0.01%	1309

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Meeder Asset Management's EVLO Position: Q4 2021 in Review

Meeder Asset Management sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2021, closing a stake of 443 shares — an estimated $61K sold.

Meeder Asset Management first reported a position in EVLO in Q1 2021 and held it in 3 quarters. The position peaked at $67K in Q2 2021. 66 funds tracked by Wall St. Rank hold EVLO as of Q4 2021.

Meeder Asset Management reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Meeder Asset Management sold 443 Evelo Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $61K.
Meeder Asset Management first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Meeder Asset Management's Evelo Biosciences, Inc. Common Stock position peaked at $67K in Q2 2021.
66 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.